Jasper Hellweg
Jasper Hellweg is a financial analyst at Argus Research and founder of ineedthis inc. and Hellweg & Cloutier, with a background in equity research and entrepreneurship. He is known for his work in investment analysis and co-founding multiple business ventures.
Claims from Jasper Hellweg
Jasper Hellweg"Given the positive initial results of the melanoma study, management has updated its estimated timeline for a potential approval to 2027, accelerating our expectations for the company to achieve a return to stable growth."Oct 12, 2026
Controversy:Will FDA Approve a Skin Cancer Vaccine by 2028?